Synopses
Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood
Patients who have Lyme neuroborreliosis (LNB) might experience lingering symptoms that persist despite antibiotic drug therapy. We tested whether those symptoms are caused by maladaptive immune responses by measuring 20 immune mediators in serum and cerebrospinal fluid (CSF) in 79 LNB patients followed for 1 year. At study entry, most mediators were highly concentrated in CSF, the site of the infection. Those responses resolved with antibiotic therapy, and associations between CSF cytokines and signs and symptoms of LNB were no longer observed. In contrast, subjective symptoms that persisted after use of antibiotics were associated with increased levels of serum interferon-α (IFN-α), which were already observed at study entry, and remained increased at each subsequent timepoint. Highest IFN-α levels corresponded with severe disease. Although the infection serves as the initial trigger, sequelae after antibiotic therapy are associated with unremitting systemic IFN-α levels, consistent with the pathogenic role of this cytokine in interferonopathies in other conditions.
EID | Hernández SA, Ogrinc K, Korva M, Kastrin A, Bogovič P, Rojko T, et al. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerg Infect Dis. 2023;29(6):1091-1101. https://doi.org/10.3201/eid2906.221685 |
---|---|
AMA | Hernández SA, Ogrinc K, Korva M, et al. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerging Infectious Diseases. 2023;29(6):1091-1101. doi:10.3201/eid2906.221685. |
APA | Hernández, S. A., Ogrinc, K., Korva, M., Kastrin, A., Bogovič, P., Rojko, T....Strle, K. (2023). Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerging Infectious Diseases, 29(6), 1091-1101. https://doi.org/10.3201/eid2906.221685. |
Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021
We describe animal-to-human transmission of SARS-CoV-2 in a zoo setting in Indiana, USA. A vaccinated African lion with physical limitations requiring hand feeding tested positive for SARS-CoV-2 after onset of respiratory signs. Zoo employees were screened, monitored prospectively for onset of symptoms, then rescreened as indicated; results were confirmed by using reverse transcription PCR and whole-genome virus sequencing when possible. Traceback investigation narrowed the source of infection to 1 of 6 persons. Three exposed employees subsequently had onset of symptoms, 2 with viral genomes identical to the lion’s. Forward contact tracing investigation confirmed probable lion-to-human transmission. Close contact with large cats is a risk factor for bidirectional zoonotic SARS-CoV-2 transmission that should be considered when occupational health and biosecurity practices at zoos are designed and implemented. SARS-CoV-2 rapid testing and detection methods for big cats and other susceptible animals should be developed and validated to enable timely implementation of One Health investigations.
EID | Siegrist AA, Richardson KL, Ghai RR, Pope B, Yeadon J, Culp B, et al. Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021. Emerg Infect Dis. 2023;29(6):1102-1108. https://doi.org/10.3201/eid2906.230150 |
---|---|
AMA | Siegrist AA, Richardson KL, Ghai RR, et al. Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021. Emerging Infectious Diseases. 2023;29(6):1102-1108. doi:10.3201/eid2906.230150. |
APA | Siegrist, A. A., Richardson, K. L., Ghai, R. R., Pope, B., Yeadon, J., Culp, B....Boyer, L. V. (2023). Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021. Emerging Infectious Diseases, 29(6), 1102-1108. https://doi.org/10.3201/eid2906.230150. |
Epidemiologic Characteristics of Mpox among People Experiencing Homelessness, Los Angeles County, California, USA, 2022
In Los Angeles County, California, USA, public health surveillance identified 118 mpox cases among persons experiencing homelessness (PEH) during July–September 2022. Age and sex were similar for mpox case-patients among PEH and in the general population. Seventy-one (60%) PEH mpox case-patients were living with HIV, 35 (49%) of them virally suppressed. Hospitalization was required for 21% of case-patients because of severe disease. Sexual contact was likely the primary mode of transmission; 84% of patients reported sexual contact <3 weeks before symptom onset. PEH case-patients lived in shelters, encampments, cars, or on the street, or stayed briefly with friends or family (couch surfed). Some case-patients stayed at multiple locations during the 3-week incubation period. Public health follow-up and contact tracing detected no secondary mpox cases among PEH in congregate shelters or encampments. Equitable efforts should continue to identify, treat, and prevent mpox among PEH, who often experience severe disease.
EID | Brosnan HK, Yeh KW, Jones PS, Gokhale S, Regos-Stewart D, Tran H, et al. Epidemiologic Characteristics of Mpox among People Experiencing Homelessness, Los Angeles County, California, USA, 2022. Emerg Infect Dis. 2023;29(6):1109-1116. https://doi.org/10.3201/eid2906.230021 |
---|---|
AMA | Brosnan HK, Yeh KW, Jones PS, et al. Epidemiologic Characteristics of Mpox among People Experiencing Homelessness, Los Angeles County, California, USA, 2022. Emerging Infectious Diseases. 2023;29(6):1109-1116. doi:10.3201/eid2906.230021. |
APA | Brosnan, H. K., Yeh, K. W., Jones, P. S., Gokhale, S., Regos-Stewart, D., Tran, H....Chang, A. H. (2023). Epidemiologic Characteristics of Mpox among People Experiencing Homelessness, Los Angeles County, California, USA, 2022. Emerging Infectious Diseases, 29(6), 1109-1116. https://doi.org/10.3201/eid2906.230021. |
Tularemia is a zoonotic infection caused by Francisella tularensis. Its most typical manifestations in humans are ulceroglandular and glandular; infections in prosthetic joints are rare. We report 3 cases of F. tularensis subspecies holarctica–related prosthetic joint infection that occurred in France during 2016–2019. We also reviewed relevant literature and found only 5 other cases of Francisella-related prosthetic joint infections worldwide, which we summarized. Among those 8 patients, clinical symptoms appeared 7 days to 19 years after the joint placement and were nonspecific to tularemia. Although positive cultures are typically obtained in only 10% of tularemia cases, strains grew in all 8 of the patients. F. tularensis was initially identified in 2 patients by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; molecular methods were used for 6 patients. Surgical treatment in conjunction with long-term antimicrobial treatment resulted in favorable outcomes; no relapses were seen after 6 months of follow-up.
EID | Ponderand L, Guimard T, Lazaro E, Dupuy H, Peuchant O, Roch N, et al. Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection. Emerg Infect Dis. 2023;29(6):1117-1126. https://doi.org/10.3201/eid2906.221395 |
---|---|
AMA | Ponderand L, Guimard T, Lazaro E, et al. Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection. Emerging Infectious Diseases. 2023;29(6):1117-1126. doi:10.3201/eid2906.221395. |
APA | Ponderand, L., Guimard, T., Lazaro, E., Dupuy, H., Peuchant, O., Roch, N....Caspar, Y. (2023). Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection. Emerging Infectious Diseases, 29(6), 1117-1126. https://doi.org/10.3201/eid2906.221395. |
Babesiosis is a globally distributed parasitic infection caused by intraerythrocytic protozoa. The full spectrum of neurologic symptoms, the underlying neuropathophysiology, and neurologic risk factors are poorly understood. Our study sought to describe the type and frequency of neurologic complications of babesiosis in a group of hospitalized patients and assess risk factors that might predispose patients to neurologic complications. We reviewed medical records of adult patients who were admitted to Yale-New Haven Hospital, New Haven, Connecticut, USA, during January 2011–October 2021 with laboratory-confirmed babesiosis. More than half of the 163 patients experienced >1 neurologic symptoms during their hospital admissions. The most frequent symptoms were headache, confusion/delirium, and impaired consciousness. Neurologic symptoms were associated with high-grade parasitemia, renal failure, and history of diabetes mellitus. Clinicians working in endemic areas should recognize the range of symptoms associated with babesiosis, including neurologic.
EID | Locke S, O’Bryan J, Zubair AS, Rethana M, Moffarah A, Krause PJ, et al. Neurologic Complications of Babesiosis, United States, 2011–2021. Emerg Infect Dis. 2023;29(6):1128-1135. https://doi.org/10.3201/eid2906.221890 |
---|---|
AMA | Locke S, O’Bryan J, Zubair AS, et al. Neurologic Complications of Babesiosis, United States, 2011–2021. Emerging Infectious Diseases. 2023;29(6):1128-1135. doi:10.3201/eid2906.221890. |
APA | Locke, S., O’Bryan, J., Zubair, A. S., Rethana, M., Moffarah, A., Krause, P. J....Farhadian, S. F. (2023). Neurologic Complications of Babesiosis, United States, 2011–2021. Emerging Infectious Diseases, 29(6), 1128-1135. https://doi.org/10.3201/eid2906.221890. |
Research
SARS-CoV-2 Seroprevalence Studies in Pets, Spain
SARS-CoV-2 can infect domestic animals such as cats and dogs. The zoonotic origin of the disease requires surveillance on animals. Seroprevalence studies are useful tools for detecting previous exposure because the short period of virus shedding in animals makes detection of the virus difficult. We report on an extensive serosurvey on pets in Spain that covered 23 months. We included animals with exposure to SARS-CoV-2–infected persons, random animals, and stray animals in the study. We also evaluated epidemiologic variables such as human accumulated incidence and spatial location. We detected neutralizing antibodies in 3.59% of animals and showed a correlation between COVID-19 incidence in humans and positivity to antibody detection in pets. This study shows that more pets were infected with SARS-CoV-2 than in previous reports based on molecular research, and the findings highlight the need to establish preventive measures to avoid reverse zoonosis events.
EID | Barroso-Arévalo S, Sánchez-Morales L, Barasona JA, Domínguez L, Sánchez-Vizcaíno JM. SARS-CoV-2 Seroprevalence Studies in Pets, Spain. Emerg Infect Dis. 2023;29(6):1136-1142. https://doi.org/10.3201/eid2906.221737 |
---|---|
AMA | Barroso-Arévalo S, Sánchez-Morales L, Barasona JA, et al. SARS-CoV-2 Seroprevalence Studies in Pets, Spain. Emerging Infectious Diseases. 2023;29(6):1136-1142. doi:10.3201/eid2906.221737. |
APA | Barroso-Arévalo, S., Sánchez-Morales, L., Barasona, J. A., Domínguez, L., & Sánchez-Vizcaíno, J. M. (2023). SARS-CoV-2 Seroprevalence Studies in Pets, Spain. Emerging Infectious Diseases, 29(6), 1136-1142. https://doi.org/10.3201/eid2906.221737. |
Similar Prevalence of Plasmodium falciparum and Non–P. falciparum Malaria Infections among Schoolchildren, Tanzania
Achieving malaria elimination requires considering both Plasmodium falciparum and non–P. falciparum infections. We determined prevalence and geographic distribution of 4 Plasmodium spp. by performing PCR on dried blood spots collected within 8 regions of Tanzania during 2017. Among 3,456 schoolchildren, 22% had P. falciparum, 24% had P. ovale spp., 4% had P. malariae, and 0.3% had P. vivax infections. Most (91%) schoolchildren with P. ovale infections had low parasite densities; 64% of P. ovale infections were single-species infections, and 35% of those were detected in low malaria endemic regions. P. malariae infections were predominantly (73%) co-infections with P. falciparum. P. vivax was detected mostly in northern and eastern regions. Co-infections with >1 non–P. falciparum species occurred in 43% of P. falciparum infections. A high prevalence of P. ovale infections exists among schoolchildren in Tanzania, underscoring the need for detection and treatment strategies that target non–P. falciparum species.
EID | Sendor R, Mitchell CL, Chacky F, Mohamed A, Mhamilawa LE, Molteni F, et al. Similar Prevalence of Plasmodium falciparum and Non–P. falciparum Malaria Infections among Schoolchildren, Tanzania. Emerg Infect Dis. 2023;29(6):1143-1153. https://doi.org/10.3201/eid2906.221016 |
---|---|
AMA | Sendor R, Mitchell CL, Chacky F, et al. Similar Prevalence of Plasmodium falciparum and Non–P. falciparum Malaria Infections among Schoolchildren, Tanzania. Emerging Infectious Diseases. 2023;29(6):1143-1153. doi:10.3201/eid2906.221016. |
APA | Sendor, R., Mitchell, C. L., Chacky, F., Mohamed, A., Mhamilawa, L. E., Molteni, F....Ngasala, B. (2023). Similar Prevalence of Plasmodium falciparum and Non–P. falciparum Malaria Infections among Schoolchildren, Tanzania. Emerging Infectious Diseases, 29(6), 1143-1153. https://doi.org/10.3201/eid2906.221016. |
Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain
Centers for Disease Control and Prevention guidelines consider SARS-CoV-2 reinfection when sequential COVID-19 episodes occur >90 days apart. However, genomic diversity acquired over recent COVID-19 waves could mean previous infection provides insufficient cross-protection. We used genomic analysis to assess the percentage of early reinfections in a sample of 26 patients with 2 COVID-19 episodes separated by 20–45 days. Among sampled patients, 11 (42%) had reinfections involving different SARS-CoV-2 variants or subvariants. Another 4 cases were probable reinfections; 3 involved different strains from the same lineage or sublineage. Host genomic analysis confirmed the 2 sequential specimens belonged to the same patient. Among all reinfections, 36.4% involved non-Omicron, then Omicron lineages. Early reinfections showed no specific clinical patterns; 45% were among unvaccinated or incompletely vaccinated persons, 27% were among persons <18 years of age, and 64% of patients had no risk factors. Time between sequential positive SARS-CoV-2 PCRs to consider reinfection should be re-evaluated.
EID | Rodríguez-Grande C, Estévez A, Palomino-Cabrera R, Molero-Salinas A, Peñas-Utrilla D, Herranz M, et al. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain. Emerg Infect Dis. 2023;29(6):1154-1161. https://doi.org/10.3201/eid2906.221696 |
---|---|
AMA | Rodríguez-Grande C, Estévez A, Palomino-Cabrera R, et al. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain. Emerging Infectious Diseases. 2023;29(6):1154-1161. doi:10.3201/eid2906.221696. |
APA | Rodríguez-Grande, C., Estévez, A., Palomino-Cabrera, R., Molero-Salinas, A., Peñas-Utrilla, D., Herranz, M....de Viedma, D. (2023). Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain. Emerging Infectious Diseases, 29(6), 1154-1161. https://doi.org/10.3201/eid2906.221696. |
SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
SARS-CoV-2 transmission in Western Australia, Australia, was negligible until a wave of Omicron variant infections emerged in February 2022, when >90% of adults had been vaccinated. This unique pandemic experience enabled assessment of SARS-CoV-2 vaccine effectiveness (VE) without potential interference from background immunity from prior infection. We matched 188,950 persons who had a positive PCR test result during February–May 2022 to negative controls by age, week of test, and other possible confounders. Overall, 3-dose VE was 42.0% against infection and 81.7% against hospitalization or death. A primary series of 2 viral-vectored vaccines followed by an mRNA booster provided significantly longer protection against infection >60 days after vaccination than a 3-dose series of mRNA vaccine. In a population free from non–vaccine-derived background immunity, vaccines against the ancestral spike protein were ≈80% effective for preventing serious outcomes from infection with the SARS-CoV-2 Omicron variant.
EID | Bloomfield LE, Ngeh S, Cadby G, Hutcheon K, Effler PV. SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022. Emerg Infect Dis. 2023;29(6):1162-1172. https://doi.org/10.3201/eid2906.230130 |
---|---|
AMA | Bloomfield LE, Ngeh S, Cadby G, et al. SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022. Emerging Infectious Diseases. 2023;29(6):1162-1172. doi:10.3201/eid2906.230130. |
APA | Bloomfield, L. E., Ngeh, S., Cadby, G., Hutcheon, K., & Effler, P. V. (2023). SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022. Emerging Infectious Diseases, 29(6), 1162-1172. https://doi.org/10.3201/eid2906.230130. |
Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000–2020
Legionellosis, notably Legionnaires’ disease, is recognized globally and in New Zealand (Aotearoa) as a major cause of community-acquired pneumonia. We analyzed the temporal, geographic, and demographic epidemiology and microbiology of Legionnaires’ disease in New Zealand by using notification and laboratory-based surveillance data for 2000‒2020. We used Poisson regression models to estimate incidence rate ratios and 95% CIs to compare demographic and organism trends over 2 time periods (2000–2009 and 2010–2020). The mean annual incidence rate increased from 1.6 cases/100,000 population for 2000–2009 to 3.9 cases/100,000 population for 2010–2020. This increase corresponded with a change in diagnostic testing from predominantly serology with some culture to almost entirely molecular methods using PCR. There was also a marked shift in the identified dominant causative organism, from Legionella pneumophila to L. longbeachae. Surveillance for legionellosis could be further enhanced by greater use of molecular typing of isolates.
EID | Graham FF, Harte D, Zhang J, Fyfe C, Baker M. Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000–2020. Emerg Infect Dis. 2023;29(6):1173-1182. https://doi.org/10.3201/eid2906.221598 |
---|---|
AMA | Graham FF, Harte D, Zhang J, et al. Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000–2020. Emerging Infectious Diseases. 2023;29(6):1173-1182. doi:10.3201/eid2906.221598. |
APA | Graham, F. F., Harte, D., Zhang, J., Fyfe, C., & Baker, M. (2023). Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000–2020. Emerging Infectious Diseases, 29(6), 1173-1182. https://doi.org/10.3201/eid2906.221598. |
Risk Factors for Non-O157 Shiga Toxin–Producing Escherichia coli Infections, United States
Shiga toxin–producing Escherichia coli (STEC) causes acute diarrheal illness. To determine risk factors for non-O157 STEC infection, we enrolled 939 patients and 2,464 healthy controls in a case–control study conducted in 10 US sites. The highest population-attributable fractions for domestically acquired infections were for eating lettuce (39%), tomatoes (21%), or at a fast-food restaurant (23%). Exposures with 10%–19% population attributable fractions included eating at a table service restaurant, eating watermelon, eating chicken, pork, beef, or iceberg lettuce prepared in a restaurant, eating exotic fruit, taking acid-reducing medication, and living or working on or visiting a farm. Significant exposures with high individual-level risk (odds ratio >10) among those >1 year of age who did not travel internationally were all from farm animal environments. To markedly decrease the number of STEC-related illnesses, prevention measures should focus on decreasing contamination of produce and improving the safety of foods prepared in restaurants.
EID | Marder EP, Cui Z, Bruce BB, Richardson L, Boyle MM, Cieslak PR, et al. Risk Factors for Non-O157 Shiga Toxin–Producing Escherichia coli Infections, United States. Emerg Infect Dis. 2023;29(6):1183-1190. https://doi.org/10.3201/eid2906.221521 |
---|---|
AMA | Marder EP, Cui Z, Bruce BB, et al. Risk Factors for Non-O157 Shiga Toxin–Producing Escherichia coli Infections, United States. Emerging Infectious Diseases. 2023;29(6):1183-1190. doi:10.3201/eid2906.221521. |
APA | Marder, E. P., Cui, Z., Bruce, B. B., Richardson, L., Boyle, M. M., Cieslak, P. R....Medus, C. (2023). Risk Factors for Non-O157 Shiga Toxin–Producing Escherichia coli Infections, United States. Emerging Infectious Diseases, 29(6), 1183-1190. https://doi.org/10.3201/eid2906.221521. |
Evolution of Avian Influenza Virus (H3) with Spillover into Humans, China
The continuous evolution of avian influenza viruses (AIVs) of subtype H3 in China and the emergence of human infection with AIV subtype H3N8 highlight their threat to public health. Through surveillance in poultry-associated environments during 2009–2022, we isolated and sequenced 188 H3 AIVs across China. Performing large-scale sequence analysis with publicly available data, we identified 4 sublineages of H3 AIVs established in domestic ducks in China via multiple introductions from wild birds from Eurasia. Using full-genome analysis, we identified 126 distinct genotypes, of which the H3N2 G23 genotype predominated recently. H3N8 G25 viruses, which spilled over from birds to humans, might have been generated by reassortment between H3N2 G23, wild bird H3N8, and poultry H9N2 before February 2021. Mammal-adapted and drug-resistance substitutions occasionally occurred in H3 AIVs. Ongoing surveillance for H3 AIVs and risk assessment are imperative for potential pandemic preparedness.
EID | Yang J, Zhang Y, Yang L, Li X, Bo H, Liu J, et al. Evolution of Avian Influenza Virus (H3) with Spillover into Humans, China. Emerg Infect Dis. 2023;29(6):1191-1201. https://doi.org/10.3201/eid2906.221786 |
---|---|
AMA | Yang J, Zhang Y, Yang L, et al. Evolution of Avian Influenza Virus (H3) with Spillover into Humans, China. Emerging Infectious Diseases. 2023;29(6):1191-1201. doi:10.3201/eid2906.221786. |
APA | Yang, J., Zhang, Y., Yang, L., Li, X., Bo, H., Liu, J....Wang, D. (2023). Evolution of Avian Influenza Virus (H3) with Spillover into Humans, China. Emerging Infectious Diseases, 29(6), 1191-1201. https://doi.org/10.3201/eid2906.221786. |
Dispatches
Detection of Novel Poxvirus from Gray Seal (Halichoerus grypus), Germany
We detected a novel poxvirus from a gray seal (Halichoerus grypus) from the North Sea, Germany. The juvenile animal showed pox-like lesions and deteriorating overall health condition and was finally euthanized. Histology, electron microscopy, sequencing, and PCR confirmed a previously undescribed poxvirus of the Chordopoxvirinae subfamily, tentatively named Wadden Sea poxvirus.
EID | Pfaff F, Kramer K, King J, Franzke K, Rosenberger T, Höper D, et al. Detection of Novel Poxvirus from Gray Seal (Halichoerus grypus), Germany. Emerg Infect Dis. 2023;29(6):1202-1205. https://doi.org/10.3201/eid2906.221817 |
---|---|
AMA | Pfaff F, Kramer K, King J, et al. Detection of Novel Poxvirus from Gray Seal (Halichoerus grypus), Germany. Emerging Infectious Diseases. 2023;29(6):1202-1205. doi:10.3201/eid2906.221817. |
APA | Pfaff, F., Kramer, K., King, J., Franzke, K., Rosenberger, T., Höper, D....Beer, M. (2023). Detection of Novel Poxvirus from Gray Seal (Halichoerus grypus), Germany. Emerging Infectious Diseases, 29(6), 1202-1205. https://doi.org/10.3201/eid2906.221817. |
Tanapox, South Africa, 2022
Tanapox is a rarely diagnosed zoonosis known to be endemic to equatorial Africa. All previously reported human cases were acquired within 10° north or south of the Equator, most recently 19 years ago. We describe a human case of tanapox in South Africa (24° south of the Equator). Expanded surveillance for this pathogen is warranted.
EID | Birkhead M, Grayson W, Grobbelaar A, Msimang V, Moolla N, Mathee A, et al. Tanapox, South Africa, 2022. Emerg Infect Dis. 2023;29(6):1206-1209. https://doi.org/10.3201/eid2906.230326 |
---|---|
AMA | Birkhead M, Grayson W, Grobbelaar A, et al. Tanapox, South Africa, 2022. Emerging Infectious Diseases. 2023;29(6):1206-1209. doi:10.3201/eid2906.230326. |
APA | Birkhead, M., Grayson, W., Grobbelaar, A., Msimang, V., Moolla, N., Mathee, A....Weyer, J. (2023). Tanapox, South Africa, 2022. Emerging Infectious Diseases, 29(6), 1206-1209. https://doi.org/10.3201/eid2906.230326. |
Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung
Human infection with avian influenza A(H3N8) virus is uncommon but can lead to acute respiratory distress syndrome. In explant cultures of the human bronchus and lung, novel H3N8 virus showed limited replication efficiency in bronchial and lung tissue but had a higher replication than avian H3N8 virus in lung tissue.
EID | Hui K, Ho J, Ng K, Cheng S, Sit K, Au T, et al. Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung. Emerg Infect Dis. 2023;29(6):1210-1214. https://doi.org/10.3201/eid2906.221680 |
---|---|
AMA | Hui K, Ho J, Ng K, et al. Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung. Emerging Infectious Diseases. 2023;29(6):1210-1214. doi:10.3201/eid2906.221680. |
APA | Hui, K., Ho, J., Ng, K., Cheng, S., Sit, K., Au, T....Chan, M. (2023). Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung. Emerging Infectious Diseases, 29(6), 1210-1214. https://doi.org/10.3201/eid2906.221680. |
Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022
During February 7─September 3, 2022, a total of 39 US states experienced outbreaks of highly pathogenic avian influenza A(H5N1) virus in birds from commercial poultry farms and backyard flocks. Among persons exposed to infected birds, highly pathogenic avian influenza A(H5) viral RNA was detected in 1 respiratory specimen from 1 person.
EID | Kniss K, Sumner KM, Tastad KJ, Lewis NM, Jansen L, Julian D, et al. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022. Emerg Infect Dis. 2023;29(6):1215-1219. https://doi.org/10.3201/eid2906.230103 |
---|---|
AMA | Kniss K, Sumner KM, Tastad KJ, et al. Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022. Emerging Infectious Diseases. 2023;29(6):1215-1219. doi:10.3201/eid2906.230103. |
APA | Kniss, K., Sumner, K. M., Tastad, K. J., Lewis, N. M., Jansen, L., Julian, D....Fry, A. (2023). Risk for Infection in Humans after Exposure to Birds Infected with Highly Pathogenic Avian Influenza A(H5N1) Virus, United States, 2022. Emerging Infectious Diseases, 29(6), 1215-1219. https://doi.org/10.3201/eid2906.230103. |
Results of PCR Analysis of Mpox Clinical Samples, Sweden, 2022
We compared cycle thresholds from mpox skin lesions with other specimen sites and over time from onset of clinical signs among 104 patients in Sweden. Cycle thresholds differed by anatomic site. We identified 2 early mpox cases from anorectal swab specimens after skin samples were negative, indicating necessity of sampling multiple sites.
EID | Edman-Wallér J, Jonsson O, Backlund G, Muradrasoli S, Sondén K. Results of PCR Analysis of Mpox Clinical Samples, Sweden, 2022. Emerg Infect Dis. 2023;29(6):1220-1222. https://doi.org/10.3201/eid2906.230253 |
---|---|
AMA | Edman-Wallér J, Jonsson O, Backlund G, et al. Results of PCR Analysis of Mpox Clinical Samples, Sweden, 2022. Emerging Infectious Diseases. 2023;29(6):1220-1222. doi:10.3201/eid2906.230253. |
APA | Edman-Wallér, J., Jonsson, O., Backlund, G., Muradrasoli, S., & Sondén, K. (2023). Results of PCR Analysis of Mpox Clinical Samples, Sweden, 2022. Emerging Infectious Diseases, 29(6), 1220-1222. https://doi.org/10.3201/eid2906.230253. |
SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom
Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021–February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating multiple human-to-cat transmissions over a prolonged period.
EID | Tyson GB, Jones S, Logan N, McDonald M, Marshall L, Murcia PR, et al. SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom. Emerg Infect Dis. 2023;29(6):1223-1227. https://doi.org/10.3201/eid2906.221755 |
---|---|
AMA | Tyson GB, Jones S, Logan N, et al. SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom. Emerging Infectious Diseases. 2023;29(6):1223-1227. doi:10.3201/eid2906.221755. |
APA | Tyson, G. B., Jones, S., Logan, N., McDonald, M., Marshall, L., Murcia, P. R....Hosie, M. J. (2023). SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom. Emerging Infectious Diseases, 29(6), 1223-1227. https://doi.org/10.3201/eid2906.221755. |
Ranid Herpesvirus 3 Infection in Common Frog Rana temporaria Tadpoles
Ranid herpesvirus 3 (RaHV3) is a recently discovered virus associated with skin disease in frogs. We detected RaHV3 DNA in free-ranging common frog (Rana temporaria) tadpoles, consistent with premetamorphic infection. Our finding reveals a critical aspect of RaHV3 pathogenesis, relevant for amphibian ecology and conservation and, potentially, for human health.
EID | Origgi FC, Taugbøl A. Ranid Herpesvirus 3 Infection in Common Frog Rana temporaria Tadpoles. Emerg Infect Dis. 2023;29(6):1228-1231. https://doi.org/10.3201/eid2906.230255 |
---|---|
AMA | Origgi FC, Taugbøl A. Ranid Herpesvirus 3 Infection in Common Frog Rana temporaria Tadpoles. Emerging Infectious Diseases. 2023;29(6):1228-1231. doi:10.3201/eid2906.230255. |
APA | Origgi, F. C., & Taugbøl, A. (2023). Ranid Herpesvirus 3 Infection in Common Frog Rana temporaria Tadpoles. Emerging Infectious Diseases, 29(6), 1228-1231. https://doi.org/10.3201/eid2906.230255. |
Baylisascaris procyonis Roundworm Infection in Child with Autism Spectrum Disorder, Washington, USA, 2022
We describe a case of Baylisascaris procyonis roundworm infection in a child in Washington, USA, with autism spectrum disorder. Environmental assessment confirmed nearby raccoon habitation and B. procyonis eggs. B. procyonis infections should be considered a potential cause of human eosinophilic meningitis, particularly among young children and persons with developmental delays.
EID | Lipton BA, Oltean HN, Capron RB, Hamlet A, Montgomery SP, Chancey RJ, et al. Baylisascaris procyonis Roundworm Infection in Child with Autism Spectrum Disorder, Washington, USA, 2022. Emerg Infect Dis. 2023;29(6):1232-1235. https://doi.org/10.3201/eid2906.230290 |
---|---|
AMA | Lipton BA, Oltean HN, Capron RB, et al. Baylisascaris procyonis Roundworm Infection in Child with Autism Spectrum Disorder, Washington, USA, 2022. Emerging Infectious Diseases. 2023;29(6):1232-1235. doi:10.3201/eid2906.230290. |
APA | Lipton, B. A., Oltean, H. N., Capron, R. B., Hamlet, A., Montgomery, S. P., Chancey, R. J....Steffl, K. E. (2023). Baylisascaris procyonis Roundworm Infection in Child with Autism Spectrum Disorder, Washington, USA, 2022. Emerging Infectious Diseases, 29(6), 1232-1235. https://doi.org/10.3201/eid2906.230290. |
MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination
We developed an ELISPOT assay for evaluating Middle East respiratory syndrome coronavirus (MERS-CoV)‒specific T-cell responses in dromedary camels. After single modified vaccinia virus Ankara-MERS-S vaccination, seropositive camels showed increased levels of MERS-CoV‒specific T cells and antibodies, indicating suitability of camel vaccinations in disease-endemic areas as a promising approach to control infection.
EID | Meyer zu Natrup C, Schünemann L, Saletti G, Clever S, Herder V, Joseph S, et al. MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination. Emerg Infect Dis. 2023;29(6):1236-1239. https://doi.org/10.3201/eid2906.230128 |
---|---|
AMA | Meyer zu Natrup C, Schünemann L, Saletti G, et al. MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination. Emerging Infectious Diseases. 2023;29(6):1236-1239. doi:10.3201/eid2906.230128. |
APA | Meyer zu Natrup, C., Schünemann, L., Saletti, G., Clever, S., Herder, V., Joseph, S....Volz, A. (2023). MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination. Emerging Infectious Diseases, 29(6), 1236-1239. https://doi.org/10.3201/eid2906.230128. |
High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
We performed 2 surveys during 2022 to estimate point prevalences of SARS-CoV-2 infection compared with overall seroprevalence in Sweden. Point prevalence was 1.4% in March and 1.5% in September. Estimated seroprevalence was >80%, including among unvaccinated children. Continued SARS-CoV-2 surveillance is necessary for detecting emerging, possibly more pathogenic variants.
EID | Groenheit R, Bacchus P, Galanis I, Sondén K, Bujila I, Efimova T, et al. High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022. Emerg Infect Dis. 2023;29(6):1240-1243. https://doi.org/10.3201/eid2906.221862 |
---|---|
AMA | Groenheit R, Bacchus P, Galanis I, et al. High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022. Emerging Infectious Diseases. 2023;29(6):1240-1243. doi:10.3201/eid2906.221862. |
APA | Groenheit, R., Bacchus, P., Galanis, I., Sondén, K., Bujila, I., Efimova, T....Klingström, J. (2023). High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022. Emerging Infectious Diseases, 29(6), 1240-1243. https://doi.org/10.3201/eid2906.221862. |
Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China
Two novel reassortant highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2 were identified in dead migratory birds in China in November 2021. The viruses probably evolved among wild birds through different flyways connecting Europe and Asia. Their low antigenic reaction to vaccine antiserum indicates high risks to poultry and to public health.
EID | Yang J, Zhang C, Yuan Y, Sun J, Lu L, Sun H, et al. Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China. Emerg Infect Dis. 2023;29(6):1244-1249. https://doi.org/10.3201/eid2906.221723 |
---|---|
AMA | Yang J, Zhang C, Yuan Y, et al. Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China. Emerging Infectious Diseases. 2023;29(6):1244-1249. doi:10.3201/eid2906.221723. |
APA | Yang, J., Zhang, C., Yuan, Y., Sun, J., Lu, L., Sun, H....Bi, Y. (2023). Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China. Emerging Infectious Diseases, 29(6), 1244-1249. https://doi.org/10.3201/eid2906.221723. |
Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama
We detected Leishmania RNA virus 1 (LRV1) in 11 isolates of Leishmania (Viannia) panamensis collected during 2014–2019 from patients from different geographic areas in Panama. The distribution suggested a spread of LRV1 in L. (V.) panamensis parasites. We found no association between LRV1 and an increase in clinical pathology.
EID | Gonzalez K, De León SS, Pineda V, Samudio F, Capitan-Barrios Z, Suarez J, et al. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama. Emerg Infect Dis. 2023;29(6):1250-1253. https://doi.org/10.3201/eid2906.220012 |
---|---|
AMA | Gonzalez K, De León SS, Pineda V, et al. Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama. Emerging Infectious Diseases. 2023;29(6):1250-1253. doi:10.3201/eid2906.220012. |
APA | Gonzalez, K., De León, S. S., Pineda, V., Samudio, F., Capitan-Barrios, Z., Suarez, J....Ábrego, L. E. (2023). Detection of Leishmania RNA Virus 1 in Leishmania (Viannia) panamensis Isolates, Panama. Emerging Infectious Diseases, 29(6), 1250-1253. https://doi.org/10.3201/eid2906.220012. |
Novel Orthonairovirus Isolated from Ticks near China–North Korea Border
We isolated a new orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border. Phylogenetic analysis showed 71.9%–73.0% nucleic acid identity to the recently discovered Songling orthonairovirus, which causes febrile illness in humans. We recommend enhanced surveillance for infection by this new virus among humans and livestock.
EID | Li F, Li J, Song J, Yin Q, Nie K, Xu S, et al. Novel Orthonairovirus Isolated from Ticks near China–North Korea Border. Emerg Infect Dis. 2023;29(6):1254-1257. https://doi.org/10.3201/eid2906.230056 |
---|---|
AMA | Li F, Li J, Song J, et al. Novel Orthonairovirus Isolated from Ticks near China–North Korea Border. Emerging Infectious Diseases. 2023;29(6):1254-1257. doi:10.3201/eid2906.230056. |
APA | Li, F., Li, J., Song, J., Yin, Q., Nie, K., Xu, S....Wang, H. (2023). Novel Orthonairovirus Isolated from Ticks near China–North Korea Border. Emerging Infectious Diseases, 29(6), 1254-1257. https://doi.org/10.3201/eid2906.230056. |
Enterovirus D68 Outbreak in Children, Finland, August–September 2022
We observed an intense enterovirus D68 outbreak in children in southwest Finland in August–September 2022. We confirmed enterovirus D68 infection in 56 children hospitalized for respiratory illnesses and in 1 child with encephalitis but were not able to test all suspected patients. Continuing surveillance for enterovirus D68 is needed.
EID | Peltola V, Österback R, Waris M, Ivaska L, Tähtinen PA, Laine M, et al. Enterovirus D68 Outbreak in Children, Finland, August–September 2022. Emerg Infect Dis. 2023;29(6):1258-1261. https://doi.org/10.3201/eid2906.221795 |
---|---|
AMA | Peltola V, Österback R, Waris M, et al. Enterovirus D68 Outbreak in Children, Finland, August–September 2022. Emerging Infectious Diseases. 2023;29(6):1258-1261. doi:10.3201/eid2906.221795. |
APA | Peltola, V., Österback, R., Waris, M., Ivaska, L., Tähtinen, P. A., Laine, M....Vuorinen, T. (2023). Enterovirus D68 Outbreak in Children, Finland, August–September 2022. Emerging Infectious Diseases, 29(6), 1258-1261. https://doi.org/10.3201/eid2906.221795. |
Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA
A 33-year-old man in Baltimore, Maryland, USA, with untreated HIV infection had a 74-day course of mpox with multiorgan system involvement and unique clinical findings. In this clinical experience combining 3 novel therapeutic regimens, this patient died from severe mpox in the context of untreated HIV and advanced immunodeficiency.
EID | Filippov E, Duhan S, Lehman L, Keisham B, Sethi V. Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA. Emerg Infect Dis. 2023;29(6):1262-1265. https://doi.org/10.3201/eid2906.230059 |
---|---|
AMA | Filippov E, Duhan S, Lehman L, et al. Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA. Emerging Infectious Diseases. 2023;29(6):1262-1265. doi:10.3201/eid2906.230059. |
APA | Filippov, E., Duhan, S., Lehman, L., Keisham, B., & Sethi, V. (2023). Treatment Failure in Patient with Severe Mpox and Untreated HIV, Maryland, USA. Emerging Infectious Diseases, 29(6), 1262-1265. https://doi.org/10.3201/eid2906.230059. |
Research Letters
Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection
Nocardia can cause systemic infections with varying manifestations. Resistance patterns vary by species. We describe N. otitidiscavarium infection with pulmonary and cutaneous manifestations in a man in the United States. He received multidrug treatment that included trimethoprim/sulfamethoxazole but died. Our case highlights the need to treat with combination therapy until drug susceptibilities are known.
EID | Fu K, White K, Ramaniuk A, Kollu V, Urbine D. Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection. Emerg Infect Dis. 2023;29(6):1266-1267. https://doi.org/10.3201/eid2906.221854 |
---|---|
AMA | Fu K, White K, Ramaniuk A, et al. Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection. Emerging Infectious Diseases. 2023;29(6):1266-1267. doi:10.3201/eid2906.221854. |
APA | Fu, K., White, K., Ramaniuk, A., Kollu, V., & Urbine, D. (2023). Manifestations and Management of Trimethoprim/Sulfamethoxazole–Resistant Nocardia otitidiscaviarum Infection. Emerging Infectious Diseases, 29(6), 1266-1267. https://doi.org/10.3201/eid2906.221854. |
Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on Leg, Tucson, Arizona, USA
We report a 34-year-old man who had a nonhealing, verrucous plaque with central ulceration on the lower leg. This case-patient is a rare example of endemic limited cutaneous leishmaniasis in Tucson, Arizona, USA. Clinicians should be aware of this disease because its manifestations can vary for individual patients.
EID | Dagenet CB, Davis MS, Murphy S, Thiede R, Culpepper KS, Fazel M. Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on Leg, Tucson, Arizona, USA. Emerg Infect Dis. 2023;29(6):1268-1269. https://doi.org/10.3201/eid2906.230125 |
---|---|
AMA | Dagenet CB, Davis MS, Murphy S, et al. Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on Leg, Tucson, Arizona, USA. Emerging Infectious Diseases. 2023;29(6):1268-1269. doi:10.3201/eid2906.230125. |
APA | Dagenet, C. B., Davis, M. S., Murphy, S., Thiede, R., Culpepper, K. S., & Fazel, M. (2023). Limited Cutaneous Leishmaniasis as Ulcerated Verrucous Plaque on Leg, Tucson, Arizona, USA. Emerging Infectious Diseases, 29(6), 1268-1269. https://doi.org/10.3201/eid2906.230125. |
Genomic Surveillance of Monkeypox Virus, Minas Gerais, Brazil, 2022
Phylogenetic analysis of 34 monkeypox virus genome sequences isolated from patients in Minas Gerais, Brazil, revealed initial importation events in early June 2022, then community transmission within the state. All generated genomes belonged to the B.1 lineage responsible for a global mpox outbreak. These findings can inform public health measures.
EID | Guimarães NR, Tomé LR, Lamounier LO, Silva MF, Lima MT, da Costa AB, et al. Genomic Surveillance of Monkeypox Virus, Minas Gerais, Brazil, 2022. Emerg Infect Dis. 2023;29(6):1270-1273. https://doi.org/10.3201/eid2906.230113 |
---|---|
AMA | Guimarães NR, Tomé LR, Lamounier LO, et al. Genomic Surveillance of Monkeypox Virus, Minas Gerais, Brazil, 2022. Emerging Infectious Diseases. 2023;29(6):1270-1273. doi:10.3201/eid2906.230113. |
APA | Guimarães, N. R., Tomé, L. R., Lamounier, L. O., Silva, M. F., Lima, M. T., da Costa, A. B....de Melo Iani, F. C. (2023). Genomic Surveillance of Monkeypox Virus, Minas Gerais, Brazil, 2022. Emerging Infectious Diseases, 29(6), 1270-1273. https://doi.org/10.3201/eid2906.230113. |
Antimicrobial-Resistant Infections after Turkey/Syria Earthquakes, 2023
Increased rates of multidrug-resistant microbes have been reported after earthquakes. After the 2023 earthquakes in Turkey and Syria, the number of associated highly drug-resistant pathogens and nosocomial transmission will probably surge in hospitals treating injured patients. It is not too late to act to prevent antimicrobial-resistant infections from compounding these tragedies.
EID | Rizk A, Abou Fayad A, Haraoui L. Antimicrobial-Resistant Infections after Turkey/Syria Earthquakes, 2023. Emerg Infect Dis. 2023;29(6):1273-1275. https://doi.org/10.3201/eid2906.230316 |
---|---|
AMA | Rizk A, Abou Fayad A, Haraoui L. Antimicrobial-Resistant Infections after Turkey/Syria Earthquakes, 2023. Emerging Infectious Diseases. 2023;29(6):1273-1275. doi:10.3201/eid2906.230316. |
APA | Rizk, A., Abou Fayad, A., & Haraoui, L. (2023). Antimicrobial-Resistant Infections after Turkey/Syria Earthquakes, 2023. Emerging Infectious Diseases, 29(6), 1273-1275. https://doi.org/10.3201/eid2906.230316. |
Detection of Severe Murine Typhus by Nanopore Targeted Sequencing, China
We report a case of murine typhus in China caused by Rickettsia typhi and diagnosed by nanopore targeted sequencing of a bronchoalveolar lavage fluid sample. This case highlights that nanopore targeted sequencing can effectively detect clinically unexplained infections and be especially useful for detecting infections in patients without typical signs and symptoms.
EID | Qian P, He X, Yang M, Wei L, Zhang L, Xing X. Detection of Severe Murine Typhus by Nanopore Targeted Sequencing, China. Emerg Infect Dis. 2023;29(6):1275-1277. https://doi.org/10.3201/eid2906.221929 |
---|---|
AMA | Qian P, He X, Yang M, et al. Detection of Severe Murine Typhus by Nanopore Targeted Sequencing, China. Emerging Infectious Diseases. 2023;29(6):1275-1277. doi:10.3201/eid2906.221929. |
APA | Qian, P., He, X., Yang, M., Wei, L., Zhang, L., & Xing, X. (2023). Detection of Severe Murine Typhus by Nanopore Targeted Sequencing, China. Emerging Infectious Diseases, 29(6), 1275-1277. https://doi.org/10.3201/eid2906.221929. |
Mycobacterium marinum Infection after Iguana Bite in Costa Rica
Infections after reptile bites are uncommon, and microbial etiologies are not well defined. We describe a case of Mycobacterium marinum soft-tissue infection after an iguana bite in Costa Rica that was diagnosed through 16S rRNA sequencing and mycobacterial culture. This case informs providers of potential etiologies of infection after iguana bites.
EID | Mah J, Walding K, Liang B, Rinsky L, Mathew R, Budvytiene I, et al. Mycobacterium marinum Infection after Iguana Bite in Costa Rica. Emerg Infect Dis. 2023;29(6):1278-1280. https://doi.org/10.3201/eid2906.230062 |
---|---|
AMA | Mah J, Walding K, Liang B, et al. Mycobacterium marinum Infection after Iguana Bite in Costa Rica. Emerging Infectious Diseases. 2023;29(6):1278-1280. doi:10.3201/eid2906.230062. |
APA | Mah, J., Walding, K., Liang, B., Rinsky, L., Mathew, R., Budvytiene, I....Banaei, N. (2023). Mycobacterium marinum Infection after Iguana Bite in Costa Rica. Emerging Infectious Diseases, 29(6), 1278-1280. https://doi.org/10.3201/eid2906.230062. |
Microscopic Evidence of Malaria Infection in Visceral Tissue from Medici Family, Italy
Microscopy of mummified visceral tissue from a Medici family member in Italy identified a potential blood vessel containing erythrocytes. Giemsa staining, atomic force microscopy, and immunohistochemistry confirmed Plasmodium falciparum inside those erythrocytes. Our results indicate an ancient Mediterranean presence of P. falciparum, which remains responsible for most malaria deaths in Africa.
EID | Maixner F, Drescher D, Boccalini G, Piombino-Mascali D, Janko M, Berens-Riha N, et al. Microscopic Evidence of Malaria Infection in Visceral Tissue from Medici Family, Italy. Emerg Infect Dis. 2023;29(6):1280-1283. https://doi.org/10.3201/eid2906.230134 |
---|---|
AMA | Maixner F, Drescher D, Boccalini G, et al. Microscopic Evidence of Malaria Infection in Visceral Tissue from Medici Family, Italy. Emerging Infectious Diseases. 2023;29(6):1280-1283. doi:10.3201/eid2906.230134. |
APA | Maixner, F., Drescher, D., Boccalini, G., Piombino-Mascali, D., Janko, M., Berens-Riha, N....Zink, A. (2023). Microscopic Evidence of Malaria Infection in Visceral Tissue from Medici Family, Italy. Emerging Infectious Diseases, 29(6), 1280-1283. https://doi.org/10.3201/eid2906.230134. |
Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
The US Coast Guard Academy began adenovirus vaccination of incoming cadets in 2022. Of 294 vaccine recipients, 15%–20% had mild respiratory or systemic symptoms within 10 days postvaccination but no serious adverse events after 90 days. Our findings support the continued use of adenovirus vaccines in congregate military settings.
EID | Iskander J, Blanchet S, Springer C, Rockwell P, Thomas D, Pillai S. Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States. Emerg Infect Dis. 2023;29(6):1283-1285. https://doi.org/10.3201/eid2906.230331 |
---|---|
AMA | Iskander J, Blanchet S, Springer C, et al. Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States. Emerging Infectious Diseases. 2023;29(6):1283-1285. doi:10.3201/eid2906.230331. |
APA | Iskander, J., Blanchet, S., Springer, C., Rockwell, P., Thomas, D., & Pillai, S. (2023). Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States. Emerging Infectious Diseases, 29(6), 1283-1285. https://doi.org/10.3201/eid2906.230331. |
Isolated Ocular Mpox without Skin Lesions, United States
We report a case of a 53-year-old HIV-negative patient in San Francisco, California, USA, with no classic mpox prodromal symptoms or skin lesions who experienced fulminant, vision-threatening scleritis, keratitis, and uveitis. Deep sequence analysis identified monkeypox virus RNA in the aqueous humor. We confirmed the virus on the cornea and sclera by PCR.
EID | Nguyen MT, Mentreddy A, Schallhorn J, Chan M, Aung S, Doernberg SB, et al. Isolated Ocular Mpox without Skin Lesions, United States. Emerg Infect Dis. 2023;29(6):1285-1288. https://doi.org/10.3201/eid2906.230032 |
---|---|
AMA | Nguyen MT, Mentreddy A, Schallhorn J, et al. Isolated Ocular Mpox without Skin Lesions, United States. Emerging Infectious Diseases. 2023;29(6):1285-1288. doi:10.3201/eid2906.230032. |
APA | Nguyen, M. T., Mentreddy, A., Schallhorn, J., Chan, M., Aung, S., Doernberg, S. B....Seitzman, G. D. (2023). Isolated Ocular Mpox without Skin Lesions, United States. Emerging Infectious Diseases, 29(6), 1285-1288. https://doi.org/10.3201/eid2906.230032. |
National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021–December 2022
Pediatric acute hepatitis of unknown etiology has been reported globally since April 2022. In Japan, 139 possible cases with onset dates after October 2021 were reported as of December 2022. Three patients required liver transplants, but none died. Rates of adenovirus positivity (11/125, 9%) were lower than those for other countries.
EID | Otake S, Ikenoue C, Sudani N, Kobayashi M, Takahashi K, Shimada T, et al. National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021–December 2022. Emerg Infect Dis. 2023;29(6):1288-1291. https://doi.org/10.3201/eid2906.221579 |
---|---|
AMA | Otake S, Ikenoue C, Sudani N, et al. National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021–December 2022. Emerging Infectious Diseases. 2023;29(6):1288-1291. doi:10.3201/eid2906.221579. |
APA | Otake, S., Ikenoue, C., Sudani, N., Kobayashi, M., Takahashi, K., Shimada, T....Sunagawa, T. (2023). National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021–December 2022. Emerging Infectious Diseases, 29(6), 1288-1291. https://doi.org/10.3201/eid2906.221579. |
Online Reports
One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern
A carbapenem-resistant Enterobacterales outbreak at a veterinary teaching hospital in the United States increased urgency for improved communication among diagnostic laboratories, public health authorities, veterinarians, and pet owners. Kansas State University, University of Missouri, Kansas Department of Health and Environment, and Veterinary Laboratory Investigation and Response Network created a surveillance, storage, and reporting protocol for veterinary antimicrobial-resistant bacteria; determined frequency of those bacteria in companion animals during 2018–2021; and created educational flyers for veterinarians and pet owners. We recommend a One Health strategy to create efficient surveillance programs to identify and report antimicrobial-resistant bacteria and educate veterinarians and pet owners about transmission risks.
EID | KuKanich K, Burklund A, McGaughey R, Muturi N, Thomason S, Chengappa M, et al. One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern. Emerg Infect Dis. 2023;29(6):1-9. https://doi.org/10.3201/eid2906.221648 |
---|---|
AMA | KuKanich K, Burklund A, McGaughey R, et al. One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern. Emerging Infectious Diseases. 2023;29(6):1-9. doi:10.3201/eid2906.221648. |
APA | KuKanich, K., Burklund, A., McGaughey, R., Muturi, N., Thomason, S., Chengappa, M....Gull, T. (2023). One Health Approach for Reporting Veterinary Carbapenem-Resistant Enterobacterales and Other Bacteria of Public Health Concern. Emerging Infectious Diseases, 29(6), 1-9. https://doi.org/10.3201/eid2906.221648. |
About the Cover
“Unassisted by Education, and Unfettered by the Rules of Art”
EID | Breedlove B. “Unassisted by Education, and Unfettered by the Rules of Art”. Emerg Infect Dis. 2023;29(6):1292-1293. https://doi.org/10.3201/eid2906.ac2906 |
---|---|
AMA | Breedlove B. “Unassisted by Education, and Unfettered by the Rules of Art”. Emerging Infectious Diseases. 2023;29(6):1292-1293. doi:10.3201/eid2906.ac2906. |
APA | Breedlove, B. (2023). “Unassisted by Education, and Unfettered by the Rules of Art”. Emerging Infectious Diseases, 29(6), 1292-1293. https://doi.org/10.3201/eid2906.ac2906. |